Mycophenolate mofetil and Requip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Requip (ropinirole hydrochloride). Common drug interactions include limb injury among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Requip. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

On Jul, 11, 2026

20 people who take Mycophenolate mofetil and Requip together, and have interactions are studied.

Mycophenolate mofetil and Requip drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Requip, by gender? *:

female:

Limb injury
Nausea (feeling of having an urge to vomit)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Physical assault
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Nephrolithiasis (calculi in the kidneys)
Abasia (inability to walk)
Aphonia (inability to produce voice)
Diarrhoea

male:

Fall
Lymphoproliferative disorder (a medical condition in which the immune system makes too many white blood cells)
Lymphoma (cancer that begins in immune system cells)
Malaise (a feeling of general discomfort or uneasiness)
Renal failure chronic (long lasting kidney dysfunction)
Vomiting
Nephrolithiasis (calculi in the kidneys)
Death
Diarrhoea
Gastrointestinal pain

What are the common drug interactions of Mycophenolate Mofetil and Requip, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abasia (inability to walk)
Arthralgia (joint pain)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Impaired healing
Joint contracture (a permanent shortening of a muscle or joint)
Joint stiffness
Muscular weakness (muscle weakness)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema (fluid collection in tissue)
Pain

30-39:

Abasia (inability to walk)
Anxiety
Emotional distress
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
General physical health deterioration (weak health status)
Injury
Mobility decreased (ability to move is reduced)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Norovirus test positive
Pain

40-49:

Kidney transplant rejection
Renal failure chronic (long lasting kidney dysfunction)

50-59:

Coronary arterial stent insertion
Limb injury
Nausea (feeling of having an urge to vomit)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Physical assault
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cataplexy (loss of muscle tone accompanied by full conscious awareness)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Nephrolithiasis (calculi in the kidneys)

60+:

Death
Diarrhoea
Urticaria (rash of round, red welts on the skin that itch intensely)
Vomiting
Gastrointestinal pain
Hyperhidrosis (abnormally increased sweating)
Ileus (a painful obstruction of the ileum or other part of the intestine)
Intestinal obstruction
Lymphoma (cancer that begins in immune system cells)
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Pain: 5 people, 25.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 25.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 25.00%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 3 people, 15.00%
Nuclear Magnetic Resonance Imaging Brain: 2 people, 10.00%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 10.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.00%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 2 people, 10.00%
Chest Pain: 2 people, 10.00%
Arrhythmias (irregular heartbeat): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Requip?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously